Text Size

Influenza Vaccine Postpartum Questionnaire

This study has been completed.
Sponsor:
Information provided by:
St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier:
NCT00401700
First received: November 17, 2006
Last updated: May 25, 2011
Last verified: May 2011
History of Changes
  Purpose

The purpose of this trial is to assess the knowledge and attitudes of post-partum women regarding influenza and the use of the influenza vaccine in pregnancy.


Condition
Influenza
Vaccine
Pregnancy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Acceptability and Feasibility of Influenza Vaccine Administration on the Post-partum Floor Prior to Discharge Home During Flu Season

Resource links provided by NLM:

MedlinePlus related topics: Flu Postpartum Care
U.S. FDA Resources

Further study details as provided by St. Michael's Hospital, Toronto:

Enrollment: 150
Study Start Date: October 2006
Study Completion Date: July 2009
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Detailed Description:

Women on our post-partum floor will be approached to complete a questionnaire which will assess their knowledge and attitudes regarding influenza and the use of the influenza vaccine in pregnancy. The study will take place over a 2-month period during influenza season, and at the time when the influenza vaccine becomes available.

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

pregnant women

Criteria

Inclusion Criteria:

  • women admitted to the postpartum floor during the study period

Exclusion Criteria:

  • inability to read or understand English
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00401700

Locations
Canada, Ontario
St. Michael's Hospital
Toronto, Ontario, Canada, M5B 1W8
Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Principal Investigator: Mark H Yudin, MD, MSc St. Michael's Hospital, Toronto, Canada
  More Information

No publications provided

Responsible Party: Dr. Mark Yudin, St. Michael's Hospital
ClinicalTrials.gov Identifier: NCT00401700     History of Changes
Other Study ID Numbers: fluvaccinesmh
Study First Received: November 17, 2006
Last Updated: May 25, 2011
Health Authority: Canada: Ethics Review Committee

Keywords provided by St. Michael's Hospital, Toronto:
influenza
influenza vaccine
pregnancy

Additional relevant MeSH terms:
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
 Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 23, 2013